Grants paid by Tj Martell Foundation for Cancer Research
EIN 51-0180178 · New York, TN · Form 990, Schedule I · NTEE H120
Tj Martell Foundation for Cancer Research of New York, TN (EIN 51-0180178) reported 19 grants paid totaling $2,688,795 to 14 recipients in tax years 2019–2024, on Form 990, Schedule I. Derived from IRS e-file data, dataset version 2026.09.0, built 2026-09-03.
Grants paid
$2,688,795
19 grants
Recipients
14
distinct organizations
Tax years
2019–2024
4 filings in the corpus
By tax year
| Tax year | Grants paid | Amount paid | Approved for future |
|---|---|---|---|
| 2019 | 8 | $1,487,500 | — |
| 2022 | 1 | $22,795 | — |
| 2023 | 2 | $178,500 | — |
| 2024 | 8 | $1,000,000 | — |
Top recipients
The 14 recipients receiving the most from Tj Martell Foundation for Cancer Research, by grants paid, out of 14 distinct recipients.
| Recipient | Match | Location | Grants | Total paid | Latest year |
|---|---|---|---|---|---|
| Vanderbilt Ingram Cancer Center 62-0476822 | A | Nashville, TN | 1 | $500,000 | 2019 |
| Children's Hospital Los Angeles 95-1690977 | A | Los Angeles, CA | 2 | $375,000 | 2024 |
| Columbia University Irving Medical Center 13-5598093 | A | New York, NY | 1 | $300,000 | 2019 |
| Vanderbilt Ingram Cancer Center 35-2528741 | A | Nashville, TN | 3 | $296,295 | 2024 |
| City of Hope | U | Duarte, CA | 2 | $225,000 | 2024 |
| University of Texas Md Anderson Cancer Center 74-6001118 | A | Houston, TX | 2 | $155,000 | 2024 |
| The Regents of the University of California San Francisco 94-3067788 | A | San Francisco, CA | 1 | $125,000 | 2024 |
| Memorial Sloan Kettering Cancer Center 13-1624082 | A | New York, NY | 1 | $125,000 | 2024 |
| Trustees of Columbia University in the City of New York | U | New York, NY | 1 | $125,000 | 2024 |
| Mount Sinai School of Medicine 13-6171197 | A | New York, NY | 1 | $125,000 | 2024 |
| Winship Cancer Institute of Emory University 58-2229271 | A | Atlanta, GA | 1 | $100,000 | 2019 |
| Md Anerson Cancer Center 76-0449960 | A | Houston, TX | 1 | $100,000 | 2019 |
| Memorial Sloan Kettering Cancer Center 13-1924236 | A | 1 | $75,000 | 2019 | |
| University of California San Francisco 94-6036493 | A | Los Angeles, CA | 1 | $62,500 | 2019 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Every grant
All 19 grant rows this organization reported, most recent first.
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2024 | University of Texas Md Anderson Cancer Center Houston, TX | A | $125,000 | paid | TO SUPPORT PHYSICIAN-SCIENTIST CAREER DEVELOPMENT PROGRAM | 202543179349309474 |
| 2024 | Mount Sinai School of Medicine New York, NY | A | $125,000 | paid | TO SUPPORT CANCER RESEARCH IN THE T.J. MARTELL MEMORIAL RESEARCH LABORATORY | 202543179349309474 |
| 2024 | The Regents of the University of California San Francisco San Francisco, CA | A | $125,000 | paid | TO SUPPORT RECIPIENT'S "BIOMARKERS FOR THERAPEUTIC STRATIFICATION IN DIFFUSE GLIMOMA" | 202543179349309474 |
| 2024 | Memorial Sloan Kettering Cancer Center New York, NY | A | $125,000 | paid | TO SUPPORT CANCER RESEARCH | 202543179349309474 |
| 2024 | Vanderbilt University Medical Center Nashville, TN | A | $125,000 | paid | TO SUPPORT RESEARCH IN THE FRANCES WILLIAMS PRESTON LABORATORY | 202543179349309474 |
| 2024 | Childern's Hospital Los Angeles Los Angeles, CA | A | $125,000 | paid | TO SUPPORT CANCER RESEARCH IN THE BOGART MEMORIAL LABORATORIES | 202543179349309474 |
| 2024 | City of Hope Duarte, CA | U | $125,000 | paid | TO SUPPORT RESEARCH IN T CELL IMMUNOTHERAPIES TO TREAT INTRACTABLE CANCERS | 202543179349309474 |
| 2024 | Trustees of Columbia University in the City of New York New York, NY | U | $125,000 | paid | TO SUPPORT CANCER RESEARCH | 202543179349309474 |
| 2023 | Vanderbilt Ingram Cancer Center Nashville, TN | A | $148,500 | paid | TO SUPPORT CANCER RESEARCH IN THE FRANCES WILLIAMS PRESTON LABORATORY | 202432619349300803 |
| 2023 | University of Texas Md Anderson Cancer Center Houston, TX | A | $30,000 | paid | TO SUPPORT CANCER RESEARCH IN THE ROBERT C. BAST LABORATORY | 202432619349300803 |
| 2022 | Vanderbilt-Ingram Cancer Center Nashville, TN | A | $22,795 | paid | TO SUPPORT CANCER RESEARCH IN THE FRANCES WILLIAMS PRESTON LABORATORY | 202302899349301600 |
| 2019 | Vanderbilt Ingram Cancer Center Nashville, TN | A | $500,000 | paid | VALIDATING BIOMARKERS IN PROSTATE CANCER TO PREDICT DISEASE OUTCOME. ESTABLISHING A TRANSLATIONAL RESEARCH LAB TO CONDUCT CLINICAL TRIALS. PHASE I TRANSLATIONAL WORK ON TWO NOVEL, ORAL DRUGS FOR TARGETING HOROMONE-REFRACTORY PROSTATE CANCER. | 202103409349300615 |
| 2019 | Columbia University Irving Medical Center New York, NY | A | $300,000 | paid | IDENTIFYING AND STUDYING CANCER STEM CELLS IN THE BLADDER. DEVELOPING BIOMARKERS TO PREDICT PROSTATE CANCER PROGNOSIS AND IMPROVING TARGETED THERAPIES THROUGH BIOMARKERS. | 202103409349300615 |
| 2019 | Children's Hospital Los Angeles Los Angeles, CA | A | $250,000 | paid | INVESTIGATING CHILDHOOD MALIGNANCIES OF THE BRAIN (NEUROBLASTOMA), BLOOD (LEUKEMIA), AND THE EYE (RETINOBLASTOMA) | 202103409349300615 |
| 2019 | City of Hope Duarte, CA | U | $100,000 | paid | CONDUCTING RESEARCH ON SMALL CELL LUNG CANCER. | 202103409349300615 |
| 2019 | Md Anerson Cancer Center Houston, TX | A | $100,000 | paid | CONDUCTING RESEARCH ON LEUKEMIA AND CANCER | 202103409349300615 |
| 2019 | Winship Cancer Institute of Emory University Atlanta, GA | A | $100,000 | paid | FACILITATING RESEARCH THAT SEEKS TO PREVENT AND TREAT CANCER BY HARNESSING THE IMMUNE SYSTEM. | 202103409349300615 |
| 2019 | Memorial Sloan Kettering Cancer Center | A | $75,000 | paid | CONDUCTING RESEARCH ON CANCER AND ASSOCIATED DISEASES | 202103409349300615 |
| 2019 | University of California San Francisco Los Angeles, CA | A | $62,500 | paid | CONDUCTING RESEARCH ON GLIOBLASTOMA | 202103409349300615 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Source filings
Every figure above is traceable to one of these IRS e-file returns by its OBJECT_ID.
| Form | Tax year | Period end | Filed | Schema | IRS OBJECT_ID |
|---|---|---|---|---|---|
| 990 | 2024 | 2024-12-31 | not stated | 2024v5.2 | 202543179349309474 |
| 990 | 2023 | 2023-12-31 | not stated | 2023v5.1 | 202432619349300803 |
| 990 | 2022 | 2022-12-31 | not stated | 2022v5.0 | 202302899349301600 |
| 990 | 2019 | 2019-12-31 | not stated | 2019v5.2 | 202103409349300615 |
Derived from IRS Form 990 e-file XML; recipient identities from the IRS Exempt Organizations Business Master File. Dataset version 2026.09.0, built 2026-09-03. The same rows as Parquet: manifest; as JSON: /api/funders/510180178.json.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.